Enovis (ENOV) Net Equity Issued and Repurchased (2011 - 2026)
Enovis' (ENOV) quarterly Net Equity Issued and Repurchased came in at $380000.0 in Q3 2026, down 51.78% year-over-year from $788000.0 in Q3 2025, and down 39.49% quarter-over-quarter from $628000.0 in Q2 2026.
Analysis
Enovis (ENOV) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends
Enovis (ENOV) has reported Net Equity Issued and Repurchased for 16 consecutive years, with $380000.0 the latest figure, recorded in Q3 2026.
- On a quarterly basis, Net Equity Issued and Repurchased fell 51.78% year-over-year to $380000.0 in Q3 2026; TTM through Jul 2026 was $1.2 million, a 34.45% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 29.67% from the prior year.
- Net Equity Issued and Repurchased was $380000.0 for Q3 2026 at Enovis, down from $628000.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $3.3 million in Q4 2022 and troughed at $104000.0 in Q3 2023.
- A 5-year average of $693529.4 and a median of $438000.0 in 2023 frame the typical range for Net Equity Issued and Repurchased.
- Across the five-year window, Net Equity Issued and Repurchased plunged 99.83% in 2022 and soared 263.46% in 2024, its largest moves.
- Over 5 years, Net Equity Issued and Repurchased stood at $3.3 million in 2022, then sank by 91.26% to $287000.0 in 2023, then advanced by 11.15% to $319000.0 in 2024, then sank by 40.75% to $189000.0 in 2025, then jumped by 101.06% to $380000.0 in 2026.
- The last three Net Equity Issued and Repurchased figures came in at $380000.0 (Q3 2026), $628000.0 (Q2 2026), and $189000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | - |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | - |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | 380,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 380,000.00 |
| Apr 3, 2026 | 628,000.00 |
| Oct 3, 2025 | 189,000.00 |
| Jul 4, 2025 | 788,000.00 |
| Apr 4, 2025 | 341,000.00 |
| Dec 31, 2024 | 319,000.00 |
| Sep 27, 2024 | 378,000.00 |
| Jun 28, 2024 | 306,000.00 |
| Mar 29, 2024 | 871,000.00 |
| Dec 31, 2023 | 287,000.00 |
| Sep 29, 2023 | 104,000.00 |
| Jun 30, 2023 | 947,000.00 |
| Mar 31, 2023 | 438,000.00 |
| Dec 31, 2022 | 3.28 Mn |
| Sep 30, 2022 | 803,000.00 |
| Jul 1, 2022 | 528,000.00 |
| Apr 1, 2022 | 1.20 Mn |
| Dec 31, 2021 | 7.00 Mn |
| Oct 1, 2021 | 8.18 Mn |
| Jul 2, 2021 | 13.37 Mn |